← Back to patent-cliff list
CAS 298-14-6
Potassium hydrogen carbonate
Codes: Lanthanum carbonate hydrate-009
Application context (from source-drug indications)
HyperphosphataemiaLanthanum carbonate hydrate高草酸尿症Lanthanum carbonate hydrate肾结石症Lanthanum carbonate hydrateCOVID-19Lanthanum carbonate hydrateChronic renal impairmentLanthanum carbonate hydrate钙过敏Lanthanum carbonate hydrate
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Lanthanum carbonate hydrate | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
Lanthanum carbonate hydrateOptimised routesteps: 2total yield: 255.28g(Lanthanum carbonate hydrate (API))
Glacial acetic acid→Lanthanum triacetate→Soda ash→Dipotassium carbonate→Ammonium bicarbonate→Potassium hydrogen carbonate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.